Scarica l'app Stockscreener
86.16
1.87%
-1.64
Dopo l'orario di chiusura:
86.44
0.28
+0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.80
Aprire:
$85.9
Volume 24 ore:
11.65M
Relative Volume:
1.27
Capitalizzazione di mercato:
$110.20B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
37.84
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
-0.35%
1M Prestazione:
-9.67%
6M Prestazione:
+9.28%
1 anno Prestazione:
+12.28%
Intervallo 1D:
$85.80
$88.86
Intervallo di 1 settimana:
$85.53
$89.93
Portata 52W:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
86.16 | 110.20B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
379.30 | 340.46B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
412.70 | 89.50B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.43 | 74.63B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
431.87 | 51.86B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Douglas Lane & Associates LLC Reduces Holdings in CVS Health Corporation $CVS - MarketBeat
Beyond Halloween night: New ways to celebrate the season - CVS Health
CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy? - Yahoo Finance
Humana surges after topping 2027 Medicare star ratings - Reuters
CVS Stock: TD Cowen Warns Of Bottom-Line Pressure For CVS Health Amid Star Ratings Setback - Yahoo Finance
CVS Health Corporation $CVS Shares Purchased by Artemis Investment Management LLP - MarketBeat
Aetna 2027 Star ratings reflect strong clinical quality and member experience - CVS Health
233,794 CVS Health Corporation $CVS Shares Acquired by Hamlin Capital Management LLC - MarketBeat
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Yahoo Finance Australia
CVS Caremark: Why transparency matters in pharmacy benefits - CVS Health
Here's Why CVS Health (CVS) is a Strong Growth Stock - Zacks Investment Research
What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032? - Yahoo Finance
CVS Health (CVS) Advances While Market Declines: Some Information for Investors - Zacks Investment Research
CVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area - CVS Health
CVS will open nearly 20 pharmacies focused on prescriptions and pharmacist care in 2026. - Stock Titan
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now? - Zacks Investment Research
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now? - Yahoo Finance UK
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead? - Yahoo Finance
CVS Health Corporation (NYSE:CVS) Stock Has Average Target Price of $107.24 - MarketBeat
CVS Health Corporation $CVS Stock Acquired by Argent Capital Management LLC - MarketBeat
Fall into wellness: Preventive health tips for older adults, a Q&A with Jean Reidy - CVS Health
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
Why Is CVS Health (NYSE:CVS) Drawing NYSE Composite Attention? - Kalkine Media
CVS Health Corporation (CVS) - Yahoo! Finance Canada
CVS Health to hold third quarter 2026 earnings conference call - marketscreener.com
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names - Zacks Investment Research
CVS Health Corporation (CVS) options chain - Yahoo Finance Australia
CVS Health Corporation $CVS Shares Sold by CX Institutional - MarketBeat
MinuteClinic is helping connect more Americans to care - CVS Health
Settling into college: Five ways students can take charge of their health - CVS Health
Cardinal Health, McKesson Extend CVS Distribution Deals to 2032 - Pharmaceutical Commerce
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
CVS Health Corporation (NYSE:CVS) Declares Quarterly Dividend of $0.67 - MarketBeat
McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health - Business Wire
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health - Yahoo Finance
CVS Health declares quarterly dividend - PR Newswire
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Zacks Investment Research
Non-operating income (total) of CVS Health Corporation – HAN:CVS - TradingView
CVS Health helps expand school-based food access for Rhode Island students - CVS Health
Hunger Action Month: Supporting healthier communities through better access to nutritious food - CVS Health
MiraSOFT™ Launch at CVS Pharmacy, Expanding the MIRA Portfolio with a Stool Softener Option - finance.yahoo.com
CVS Health Corporation (CVS) stock price, news, quote and history - Yahoo Finance UK
CVS Health Corporation (CVS) - Yahoo! Finance Canada
CVS Health (CVS) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Ask a CVS Pharmacist: Your top flu shot questions, answered - CVS Health
CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health CorporationCVS - Business Wire
CVS Health Is Making a Difference in Local Communities, One Classroom at a Time - Yahoo Finance
CVS Health (CVS) Settles Website Tracking Privacy Case For $20.5 Million - Yahoo Finance
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cvs Health Corp Azioni (CVS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
| FARAH ROGER N | Director |
May 21 '26 |
Proposed Sale |
93.68 |
2,817 |
263,886 |
0 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer |
May 08 '26 |
Sale |
89.58 |
69,551 |
6,230,379 |
10,133 |
| TILAK MANDADI | Officer |
May 08 '26 |
Proposed Sale |
89.58 |
69,551 |
6,230,719 |
0 |
2.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):